Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1999
03/30/1999US5888732 Recombinational cloning using engineered recombination sites
03/30/1999US5888731 Combining sample with three species of oligonucleotide probes under hybridization conditions, ligating hybridized probes, evaluating products
03/30/1999US5888729 Oligonucleotide probes and methods for detecting Streptococcus pneumoniae
03/30/1999US5888727 Two vsv gene products have been reported to be present in the nucleus after infection. the two gene products are the newly synthesized 47 nucleotide leader rna and a pre-existing component of infecting virions, a 30 kda protein called the
03/30/1999US5888722 Stable cell lines expressing the CFTR protein or a mutant of this protein, tool for selecting molecules having an effect on the intracellular transport of these proteins
03/30/1999US5888532 Treatment of alcoholism and related disorders with (nicotinamide-adenine dinucleotide) phosphate derivatives
03/30/1999US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae
03/30/1999US5888516 Genetic engineered protein
03/30/1999US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host
03/30/1999US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore
03/30/1999US5888507 Treatment for insulin dependent diabetes
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888503 Materials and methods for the control of calliphoridae pests
03/30/1999US5888502 Recombinant retroviruses
03/30/1999CA2249058A1 Biologically tolerated low molecular weight polyethylenimines
03/30/1999CA2166707C New stromal cell lines from human bone marrow and their use
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/30/1999CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna
03/25/1999WO1999014371A1 Dna bracketing locus compatible standards for electrophoresis
03/25/1999WO1999014370A1 De novo polynucleotide synthesis using rolling templates
03/25/1999WO1999014369A1 Techniques for identifying, confirming, mapping and categorizing polymers
03/25/1999WO1999014367A1 Method for determining propensity for developing late-onset alzheimer's disease
03/25/1999WO1999014364A1 METHOD FOR SYNTHESIZING cDNA FROM mRNA SAMPLE
03/25/1999WO1999014363A1 Genetic polymorphisms in the microsomal triglyceride transfer protein promoter and uses thereof
03/25/1999WO1999014362A1 Characterising nucleic acid by mass spectrometry
03/25/1999WO1999014359A1 Method of monitoring the competitiveness of a microbial strain
03/25/1999WO1999014356A2 P53-induced apoptosis
03/25/1999WO1999014354A1 Methods and vector constructs useful for production of recombinant aav
03/25/1999WO1999014353A2 Intrabody-mediated control of immune reactions
03/25/1999WO1999014351A1 Isoflavone biosynthetic enzymes
03/25/1999WO1999014350A1 Rank1, an ankyrin-repeat containing peptide from rice associated with disease resistance
03/25/1999WO1999014349A1 Agrobacterium-mediated transformation of turnip rape
03/25/1999WO1999014348A1 In planta transformation of plants
03/25/1999WO1999014347A1 PROTEASE-DEFICIENT STRAINS OF $i(PICHIA METHANOLICA)
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014345A2 Medicament for treating a manifested lyme disease
03/25/1999WO1999014344A1 G protein chimeras
03/25/1999WO1999014343A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999WO1999014342A1 Proteases from gram-positive organisms
03/25/1999WO1999014341A2 Proteases from gram-positive organisms
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014339A1 ASPARAGINASE PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF OBTAINABLE FROM A PARASITIC HELMINTH, IN PARTICULAR FROM $i(DIROFILARIA IMMITIS)
03/25/1999WO1999014338A1 Total synthesis and functional overexpression of a candida rugosa lip1 gene coding for a major industrial lipase
03/25/1999WO1999014337A2 New plant genes
03/25/1999WO1999014336A2 Thermostable luciferases and methods of production
03/25/1999WO1999014335A1 Yeast strains for the production of lactic acid
03/25/1999WO1999014334A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus
03/25/1999WO1999014333A2 Improved method of production of pneumococcal surface proteins
03/25/1999WO1999014332A1 Plant-origin regulator protein and nucleic acid encoding the same
03/25/1999WO1999014331A2 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014329A1 Human macrophage receptor marco
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014327A2 Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999014325A1 NOVEL Fas LIGAND DERIVATIVE
03/25/1999WO1999014324A1 Mammalian genes participating in circadian period
03/25/1999WO1999014323A1 Heregulin-gamma
03/25/1999WO1999014322A2 Allelic variant of human stat3
03/25/1999WO1999014321A1 Novel therapeutic molecules
03/25/1999WO1999014320A1 CHROMOSOMAL MUTAGENESIS IN $i(PICHIA METHANOLICA)
03/25/1999WO1999014319A1 An improved yeast interaction trap assay
03/25/1999WO1999014318A1 Method for the complete chemical synthesis and assembly of genes and genomes
03/25/1999WO1999014316A2 Synthetic hybrid plant promoter
03/25/1999WO1999014314A1 Regulation of gene expression in plants
03/25/1999WO1999014313A2 Biological systems for manufacture of polyhydroxylalkanoate polymers containing 4-hydroxyacids
03/25/1999WO1999014311A1 Method of screening for antimicrobial compounds
03/25/1999WO1999014310A1 Rna export element and methods of use
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014237A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999WO1999014236A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999014233A1 Peptides derived from cowdria ruminantium, antibodies thereto and their diagnostical and medical uses
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014230A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999WO1999014224A1 Rapid rna isolation procedure
03/25/1999WO1999013976A1 Apparatuses and methods for isolating nucleic acid
03/25/1999WO1999013915A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013907A2 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999WO1999013905A1 Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
03/25/1999WO1999013903A1 Methods and compositions for diagnosing and treating malaria
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999013893A1 Peptide nucleic acids having antibacterial activity
03/25/1999WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates
03/25/1999WO1999013719A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999WO1999013710A1 A method of treatment and an animal model useful for same
03/25/1999WO1999009194B1 Recombinant celo avian adenovirus and use as vaccinating vector
03/25/1999WO1999003985B1 Glutenin genes and their uses
03/25/1999WO1999001572A3 Methods for rapidly detecting methicillin resistant staphylococci
03/25/1999WO1999001571A3 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1998058068A3 A method for plant protection against insects or nematodes
03/25/1999WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/25/1999WO1998056813A3 Two human membrane-fusion proteins
03/25/1999WO1998055509A3 Two human dnaj-like proteins
03/25/1999WO1998055508A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
1 ... 3418 3419 3420 3421 3422 3423 3424 3425 3426 3427 3428 3429 3430 3431 3432 3433 3434 3435 3436 3437 3438 ... 4023